Literature DB >> 12164869

Effect of antioxidant therapy with dl-alpha-tocopherol on cardiovascular structure in experimental renal failure.

Kerstin Amann1, Johannes Törnig, Mareike Buzello, Alexander Kuhlmann, Marie-Luise Gross, Marcin Adamczak, Moriz Buzello, Eberhard Ritz.   

Abstract

BACKGROUND: Chronic renal failure is characterized by remodeling of the structure of the heart and the vasculature, for example, left ventricular hypertrophy, myocardial fibrosis, capillary/myocyte mismatch, as well as thickening of intramyocardial arteries and of peripheral arteries and veins. Furthermore, uremia is a state of increased oxygen stress. It was the purpose of this study to examine whether these findings are interrelated.
METHODS: To investigate whether antioxidative therapy with dl-alpha-tocopherol (Toco; vitamin E) interferes with the development of abnormal cardiovascular structure in experimental renal failure, 28 male Sprague-Dawley rats were subjected to partial renal ablation (subtotal nephrectomy, SNX) or to sham operation (sham). SNX were either left untreated or received the antioxidant Toco (2 x 1500 IE/kg BW/week in the pellets). Blood pressure was measured using tail plethysmography. The experiment was terminated after 12 weeks. Heart and left ventricular weight were determined and the following parameters were measured using morphometry and stereology: volume densities of cardiomyocytes, capillaries and non-vascular interstitium; length density and total length of cardiac capillaries, wall thickness of intramyocardial arterioles and of the aorta.
RESULTS: Systolic blood pressure and body weight were comparable in all groups. Treatment with Toco led to significantly increased plasma concentrations of Toco. Left ventricular weight and wall thickness of intramyocardial arteries were significantly higher in both SNX groups compared to sham controls. Volume density of the cardiac interstitial tissue was significantly higher in untreated SNX than in Toco treated SNX and sham control rats. Length density of capillaries was significantly lower in untreated SNX than in control rats; however, the values were significantly higher, and even higher than in sham controls, when SNX were treated with Toco.
CONCLUSIONS: Treatment with the antioxidant dl-alpha-tocopherol prevented cardiomyocyte/capillary mismatch, and to some extent also myocardial fibrosis in rats with renal failure. The results point to a role of oxidative stress in the genesis of myocardial interstitial fibrosis and capillary deficit of the heart.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12164869     DOI: 10.1046/j.1523-1755.2002.00518.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  5 in total

1.  Monocyte chemoattractant proteins mediate myocardial microvascular dysfunction in swine renovascular hypertension.

Authors:  Jing Lin; Xiangyang Zhu; Alejandro R Chade; Kyra L Jordan; Ronit Lavi; Elena Daghini; Matthew E Gibson; Angelo Guglielmotti; Amir Lerman; Lilach O Lerman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-07-23       Impact factor: 8.311

2.  High-dose enalapril treatment reverses myocardial fibrosis in experimental uremic cardiomyopathy.

Authors:  Karin Tyralla; Marcin Adamczak; Kerstin Benz; Valentina Campean; Marie-Luise Gross; Karl F Hilgers; Eberhard Ritz; Kerstin Amann
Journal:  PLoS One       Date:  2011-01-27       Impact factor: 3.240

3.  The need for a cardionephrology subspecialty.

Authors:  Javier Díez; Alberto Ortiz
Journal:  Clin Kidney J       Date:  2021-03-10

4.  Pharmacokinetics and pharmacodynamics of recombinant human EPO-Fc fusion protein in vivo.

Authors:  Xunlong Shi; Jianjun Yang; Haiyan Zhu; Li Ye; Meiqing Feng; Jiyang Li; Hai Huang; Qun Tao; Dan Ye; Lee-Hwei K Sun; Bill N C Sun; Cecily R Y Sun; Guizhen Han; Yuanyuan Liu; Minghui Yao; Pei Zhou; Dianwen Ju
Journal:  PLoS One       Date:  2013-08-19       Impact factor: 3.240

Review 5.  Microvascular disease in chronic kidney disease: the base of the iceberg in cardiovascular comorbidity.

Authors:  Uwe Querfeld; Robert H Mak; Axel Radlach Pries
Journal:  Clin Sci (Lond)       Date:  2020-06-26       Impact factor: 6.124

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.